Uncle Sam Wants You To Pay For AI Equity

Welcome to LazyListen. This is The Daily Rip for today. Markets wrapped up a short week with a mixed bag as the Dow hit a record high, buoyed by tech giants like Apple, while the S&P 500 barely moved.

The labor market showed cracks, with participation falling to its lowest level in half a century outside of the pandemic, signaling fewer people working or actively job hunting. I. and tech trends.

S. government a five percent stake in the company. I.

sector. I. innovation with taxpayers.

It’s a bold shift from the usual political rhetoric into a concrete bargaining chip ahead of OpenAI’s potential IPO. This proposal has broader implications beyond OpenAI itself. I.

I. ecosystem—from model developers to cloud providers and chipmakers. For Microsoft, which backs OpenAI, this raises a key question: does government involvement reduce the risk of regulatory roadblocks, or does it introduce a new layer of policy risk that could complicate valuations?

I. winners might now have a “sovereign shareholder” to consider, adding a fresh dynamic to the market. Turning to individual stocks, Tesla’s shares took a hit despite beating delivery expectations.

The market quickly turned that news into a sell-the-news event, reflecting ongoing skepticism about Tesla’s ability to sustain growth amid rising competition and macro uncertainties. Meanwhile, Jersey Mike’s filed to go public, aiming to capitalize on its expanding sandwich empire, a reminder that consumer brands are still looking for growth stories in a cautious environment. In the chip and memory space, SanDisk was under pressure, falling sharply as profit-taking hit memory stocks again.

-related hardware. I. growth will translate into sustained chip spending.

Among the quick movers, Genuine Parts surged after a dividend payout sparked speculation about a possible breakup, driving a revaluation trade in industrial parts suppliers. Churchill Capital XI jumped on news of a SPAC deal with Agility Robotics, keeping the momentum alive for robotics and automation plays. In biotech, Sellas Life Sciences rallied as its trial for an acute myeloid leukemia treatment neared a critical readout, fueling hopes for a breakthrough.

Moderna climbed on renewed optimism around its flu shot approval, which helped lift the broader biotech sentiment. Honeywell Aerospace’s spinoff found fresh buyers, pushing its shares higher as investors warmed to the focused aerospace play. MicroStrategy gained on a Bitcoin rebound, drawing renewed interest in crypto-related stocks as a proxy for digital asset exposure.

Apple rose nearly five percent, helped by easing cost concerns after China reportedly waived some memory chip tariffs, a positive development for its supply chain. On the downside, Lumen Technologies tumbled after its deal with Alkira failed to alleviate worries about its debt load, highlighting ongoing challenges in telecom infrastructure. IREN dropped sharply following a backlash over CEO stock grants that raised dilution fears among shareholders.

I. regulation and how the market digests OpenAI’s government stake proposal. Watch Tesla closely for follow-through after its delivery miss reaction, and monitor chipmakers for signs of stabilization or further weakness.

Earnings from key tech and industrial names could also provide fresh clues on how the economy and innovation sectors are faring as we move deeper into the third quarter. Thanks for listening. Catch you next time on LazyListen.